Construction of Recombinant Pegfp-N1-Hper2 Plasmid and Its Expression in Osteosarcoma Cells

Anyuan Cheng,Yan Zhang,Hongjun Mei,Shuo Fang,Peng Ji,Jian Yang,Ling Yu,Weichun Guo
DOI: https://doi.org/10.3892/ol.2016.4291
2016-01-01
Oncology Letters
Abstract:The aim of this study was to construct the eukaryotic expression vector pEGFP-N1-hPer2 and assess its expression in the human osteosarcoma cell line MG63. Total mRNA was extracted from human osteosarcoma MG63 cells, the human period 2 (hPer2) gene was obtained by reverse transcription-polymerase chain reaction (RT-PCR) and cloned into the pEGFP-N1 vector, then the recombinant pEGFP-N1-hPer2 plasmid was constructed and transfected into MG63 cells using Lipofectamine 2000. The expression of hPer2 in MG63 cells was measured by quantitative RT-PCR and western blot analysis. The accurate construction of pEGFP-N1-hPer2 was verified by double enzyme digestion and DNA sequencing. hPer2 gene expression in the transfected cells was assessed by RT-qPCR and western blot analysis. In conclusion, the recombinant pEGFP-N1-hPer2 plasmid was constructed successfully, and expressed effectively in MG63 cells.
What problem does this paper attempt to address?